{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T10:05:47Z","timestamp":1787652347302,"version":"build-2736575974"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100023171","name":"Life Sciences Research Board","doi-asserted-by":"publisher","award":["LSRB-297\/BTB\/2017"],"award-info":[{"award-number":["LSRB-297\/BTB\/2017"]}],"id":[{"id":"10.13039\/501100023171","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","award":["EMDR\/SG\/10\/2024\\u201300379"],"award-info":[{"award-number":["EMDR\/SG\/10\/2024\\u201300379"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018337","name":"South Asian University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018337","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001849","name":"Defence Research and Development Organisation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001849","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001407","name":"Department of Biotechnology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001407","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Enzyme and Microbial Technology"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.enzmictec.2025.110760","type":"journal-article","created":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T15:35:47Z","timestamp":1759937747000},"page":"110760","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Anti-biofilm efficiency and substrate specificity of recombinantly produced human paraoxonases"],"prefix":"10.1016","volume":"192","author":[{"given":"Manik","family":"Goel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priyamedha","family":"Yadav","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fauzia","family":"Parween","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sudisha","family":"Mukherjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1156-9596","authenticated-orcid":false,"given":"Rinkoo Devi","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.enzmictec.2025.110760_bib1","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/854391","article-title":"Human paraoxonase 1 as a pharmacologic agent: limitations and perspectives","volume":"2014","author":"Bajaj","year":"2014","journal-title":"Sci. World J."},{"key":"10.1016\/j.enzmictec.2025.110760_bib2","doi-asserted-by":"crossref","first-page":"5980","DOI":"10.3390\/molecules25245980","article-title":"The structure and function of Paraoxonase-1 and its comparison to Paraoxonase-2 and -3","volume":"25","author":"Taler-Ver\u010di\u010d","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.enzmictec.2025.110760_bib3","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1515\/pjvs-2016-0028","article-title":"A review of paraoxonase 1 properties and diagnostic applications","volume":"19","author":"Kulka","year":"2016","journal-title":"Pol. J. Vet. Sci."},{"key":"10.1016\/j.enzmictec.2025.110760_bib4","doi-asserted-by":"crossref","first-page":"44444","DOI":"10.1074\/jbc.M105660200","article-title":"Paraoxonase-2 is a ubiquitously expressed protein with antioxidant properties and is capable of preventing cell-mediated oxidative modification of low density lipoprotein","volume":"276","author":"Ng","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.enzmictec.2025.110760_bib5","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1007\/s12038-021-00234-7","article-title":"Insights into the role of paraoxonase 2 in human pathophysiology","volume":"47","author":"Parween","year":"2022","journal-title":"J. Biosci."},{"key":"10.1016\/j.enzmictec.2025.110760_bib6","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1194\/jlr.M400511-JLR200","article-title":"Human paraoxonases (PON1, PON2, and PON3) are lactonases with overlapping and distinct substrate specificities","volume":"46","author":"Draganov","year":"2005","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.enzmictec.2025.110760_bib7","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1021\/jacs.6b10801","article-title":"Active site hydrophobicity and the convergent evolution of paraoxonase activity in structurally divergent enzymes: the case of serum paraoxonase 1","volume":"139","author":"Blaha-Nelson","year":"2017","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.enzmictec.2025.110760_bib8","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1038\/nsmb767","article-title":"Structure and evolution of the serum paraoxonase family of detoxifying and anti-atherosclerotic enzymes","volume":"11","author":"Harel","year":"2004","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.enzmictec.2025.110760_bib9","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.jmb.2012.02.042","article-title":"Catalytic versatility and backups in enzyme active sites: the case of serum paraoxonase 1","volume":"418","author":"Ben-David","year":"2012","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.enzmictec.2025.110760_bib10","doi-asserted-by":"crossref","first-page":"7649","DOI":"10.1074\/jbc.M512594200","article-title":"The histidine 115-histidine 134 dyad mediates the lactonase activity of mammalian serum paraoxonases","volume":"281","author":"Khersonsky","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.enzmictec.2025.110760_bib11","doi-asserted-by":"crossref","first-page":"881","DOI":"10.3201\/eid0809.020063","article-title":"Biofilms: microbial life on surfaces","volume":"8","author":"Donlan","year":"2002","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.enzmictec.2025.110760_bib12","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2023.1137947","article-title":"Understanding bacterial biofilms: from definition to treatment strategies","volume":"13","author":"Zhao","year":"2023","journal-title":"Front. Cell Infect. Microbiol."},{"key":"10.1016\/j.enzmictec.2025.110760_bib13","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1038\/s41467-021-21748-6","article-title":"Biofilm formation in the lung contributes to virulence and drug tolerance of mycobacterium tuberculosis","volume":"12","author":"Chakraborty","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.enzmictec.2025.110760_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.tcsw.2021.100051","article-title":"Mycobacterium abscessus biofilms produce an extracellular matrix and have a distinct mycolic acid profile","volume":"7","author":"Dokic","year":"2021","journal-title":"Cell Surf."},{"key":"10.1016\/j.enzmictec.2025.110760_bib15","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1111\/jam.12272","article-title":"Adherence and biofilm formation of mycobacterium avium, mycobacterium intracellulare and mycobacterium abscessus to household plumbing materials","volume":"115","author":"Mullis","year":"2013","journal-title":"J. Appl. Microbiol."},{"key":"10.1016\/j.enzmictec.2025.110760_bib16","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2017.02651","article-title":"Mycobacterium biofilms","volume":"8","author":"Esteban","year":"2018","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.enzmictec.2025.110760_bib17","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1111\/j.1365-2958.2008.06274.x","article-title":"Growth of mycobacterium tuberculosis biofilms containing free mycolic acids and harbouring drug-tolerant bacteria","volume":"69","author":"Ojha","year":"2008","journal-title":"Mol. Microbiol."},{"key":"10.1016\/j.enzmictec.2025.110760_bib18","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1038\/s41467-024-44774-6","article-title":"Lsr2 acts as a cyclic di-GMP receptor that promotes keto-mycolic acid synthesis and biofilm formation in mycobacteria","volume":"15","author":"Ling","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.enzmictec.2025.110760_bib19","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1128\/AAC.01502-10","article-title":"J.M. Sim\u00f3, Paraoxonases as potential antibiofilm agents: their relationship with quorum-sensing signals in Gram-negative bacteria","volume":"55","author":"Camps","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.enzmictec.2025.110760_bib20","doi-asserted-by":"crossref","first-page":"388","DOI":"10.3934\/microbiol.2016.4.388","article-title":"Inhibition of pseudomonas aeruginosa biofilm formation and motilities by human serum paraoxonase (hPON1)","volume":"2","author":"Aybey","year":"2016","journal-title":"AIMS Microbiol."},{"key":"10.1016\/j.enzmictec.2025.110760_bib21","article-title":"Quorum quenching effect of recombinant Paraoxonase-1 enzyme against quorum sensing genes produced from pseudomonas aeruginosa","volume":"25","author":"Faisal","year":"2021","journal-title":"Gene Rep."},{"key":"10.1016\/j.enzmictec.2025.110760_bib22","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.femsle.2005.09.023","article-title":"Human and murine paraoxonase 1 are host modulators of pseudomonas aeruginosa quorum-sensing","volume":"253","author":"Ozer","year":"2005","journal-title":"FEMS Microbiol. Lett."},{"key":"10.1016\/j.enzmictec.2025.110760_bib23","doi-asserted-by":"crossref","first-page":"3122","DOI":"10.1021\/acschembio.6b00527","article-title":"Engineering soluble human paraoxonase 2 for quorum quenching","volume":"11","author":"Li","year":"2016","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.enzmictec.2025.110760_bib24","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1080\/10826068.2022.2101000","article-title":"Production of highly soluble native human paraoxonase 2 with potential anti-biofilm property","volume":"53","author":"Parween","year":"2023","journal-title":"Prep. Biochem. Biotechnol."},{"key":"10.1016\/j.enzmictec.2025.110760_bib25","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s11274-023-03843-6","article-title":"Anti-biofilm potential of human senescence marker protein 30 against mycobacterium smegmatis","volume":"40","author":"Yadav","year":"2023","journal-title":"World J. Microbiol. Biotechnol."},{"key":"10.1016\/j.enzmictec.2025.110760_bib26","doi-asserted-by":"crossref","first-page":"131","DOI":"10.3389\/fmicb.2016.00131","article-title":"Quorum sensing: an Under-Explored phenomenon in the phylum actinobacteria","volume":"7","author":"Polkade","year":"2016","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.enzmictec.2025.110760_bib27","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1002\/iub.1339","article-title":"Quorum sensing and biofilm formation in mycobacteria: role of c-di-GMP and methods to study this second messenger","volume":"66","author":"Sharma","year":"2014","journal-title":"IUBMB Life"},{"key":"10.1016\/j.enzmictec.2025.110760_bib28","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/j.clinbiochem.2017.04.016","article-title":"Paraoxonases and infectious diseases","volume":"50","author":"Camps","year":"2017","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.enzmictec.2025.110760_bib29","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1159\/000363700","article-title":"Serum paraoxonase 1 activity and oxidative stress in pediatric patients with pulmonary tuberculosis","volume":"23","author":"Torun","year":"2014","journal-title":"Med. Princ. Pract."},{"key":"10.1016\/j.enzmictec.2025.110760_bib30","first-page":"1118","article-title":"5,6-\u03b4-DHTL, a stable metabolite of arachidonic acid, is a potential substrate for paraoxonase 1","volume":"1851","author":"Eryanni-Levin","year":"2015","journal-title":"Biochim. Biophys. Acta (BBA) Mol. Cell Biol. Lipids"},{"key":"10.1016\/j.enzmictec.2025.110760_bib31","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.bbrc.2018.09.083","article-title":"Identification of biologically active \u03b4-lactone eicosanoids as paraoxonase substrates","volume":"505","author":"Teiber","year":"2018","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.enzmictec.2025.110760_bib32","doi-asserted-by":"crossref","first-page":"590","DOI":"10.3390\/antiox11030590","article-title":"A PON for all seasons: comparing paraoxonase enzyme substrates, activity and action including the role of PON3 in health and disease","volume":"11","author":"Mohammed","year":"2022","journal-title":"Antioxidants"},{"key":"10.1016\/j.enzmictec.2025.110760_bib33","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.bcp.2010.11.008","article-title":"Pharmacological and dietary modulators of paraoxonase 1 (PON1) activity and expression: the hunt goes on","volume":"81","author":"Costa","year":"2010","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.enzmictec.2025.110760_bib34","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1111\/jphp.13141","article-title":"A potential risk factor for paraoxonase 1: in silico and in-vitro analysis of the biological activity of proton-pump inhibitors","volume":"71","author":"T\u00fcrke\u015f","year":"2019","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.enzmictec.2025.110760_bib35","doi-asserted-by":"crossref","unstructured":"C. T\u00fcrke\u015f, Investigation of potential paraoxonase-i inhibitors by kinetic and molecular docking studies: chemotherapeutic drugs, protein & peptide letters 26 (n.d.) 392\u2013402. https:\/\/doi.org\/10.2174\/0929866526666190226162225.","DOI":"10.2174\/0929866526666190226162225"},{"key":"10.1016\/j.enzmictec.2025.110760_bib36","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2021.630551","article-title":"Challenges associated with the formation of recombinant protein inclusion bodies in escherichia coli and strategies to address them for industrial applications","volume":"9","author":"Bhatwa","year":"2021","journal-title":"Front. Bioeng. Biotechnol."},{"key":"10.1016\/j.enzmictec.2025.110760_bib37","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2014.00486","article-title":"Refolding and purification of recombinant L-asparaginase from inclusion bodies of E. Coli into active tetrameric protein","volume":"5","author":"Upadhyay","year":"2014","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.enzmictec.2025.110760_bib38","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0258879","article-title":"Association between human paraoxonase 2 protein and efficacy of acetylcholinesterase inhibiting drugs used against Alzheimer\u2019s disease","volume":"16","author":"Parween","year":"2021","journal-title":"PLOS One"},{"key":"10.1016\/j.enzmictec.2025.110760_bib39","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s12934-019-1053-9","article-title":"Evaluation of scfv protein recovery from E. Coli by in vitro refolding and mild solubilization process","volume":"18","author":"Sarker","year":"2019","journal-title":"Microb. Cell Factor."},{"key":"10.1016\/j.enzmictec.2025.110760_bib40","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.ab.2009.11.022","article-title":"Metal and substrate binding to an Fe(II) dioxygenase resolved by UV spectroscopy with global regression analysis","volume":"399","author":"Grzyska","year":"2010","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.enzmictec.2025.110760_bib41","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1016\/S0090-9556(24)15082-9","article-title":"Human serum paraoxonase (pon1) isozymes q and r hydrolyze lactones and cyclic carbonate esters","volume":"28","author":"Billecke","year":"2000","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.enzmictec.2025.110760_bib42","doi-asserted-by":"crossref","first-page":"431","DOI":"10.3390\/pharmaceutics15020431","article-title":"CSM-toxin: a web-server for predicting protein toxicity","volume":"15","author":"Morozov","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.enzmictec.2025.110760_bib43","doi-asserted-by":"crossref","first-page":"2555","DOI":"10.1128\/JCM.00666-08","article-title":"Rifampin resistance, Beijing-W clade-single nucleotide polymorphism cluster group 2 phylogeny, and the Rv2629 191-C allele in mycobacterium tuberculosis strains","volume":"46","author":"Chakravorty","year":"2008","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.enzmictec.2025.110760_bib44","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1080\/01480545.2019.1620266","article-title":"Gadolinium-based contrast agents: in vitro paraoxonase 1 inhibition, in silico studies","volume":"44","author":"Beydemir","year":"2021","journal-title":"Drug Chem. Toxicol."},{"key":"10.1016\/j.enzmictec.2025.110760_bib45","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1080\/15622975.2017.1322219","article-title":"Lowered PON1 activities are strongly associated with depression and bipolar disorder, recurrence of (hypo)mania and depression, increased disability and lowered quality of life","volume":"20","author":"Moreira","year":"2019","journal-title":"World J. Biol. Psychiatry"},{"key":"10.1016\/j.enzmictec.2025.110760_bib46","article-title":"Abnormal paraoxonase-1 (PON1) enzyme activity in idiopathic inflammatory myopathies","author":"Bae","year":"2021","journal-title":"Rheumatology"},{"key":"10.1016\/j.enzmictec.2025.110760_bib47","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.mib.2009.11.006","article-title":"To catch a killer. What can mycobacterial models teach us about mycobacterium tuberculosis pathogenesis?","volume":"13","author":"Shiloh","year":"2010","journal-title":"Curr. Opin. Microbiol."},{"key":"10.1016\/j.enzmictec.2025.110760_bib48","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/j.jiph.2020.06.023","article-title":"Features of the biochemistry of mycobacterium smegmatis, as a possible model for mycobacterium tuberculosis","volume":"13","author":"J.A.S","year":"2020","journal-title":"J. Infect. Public Health"},{"key":"10.1016\/j.enzmictec.2025.110760_bib49","doi-asserted-by":"crossref","first-page":"105","DOI":"10.15698\/mic2019.02.667","article-title":"The extracellular matrix of mycobacterial biofilms: could we shorten the treatment of mycobacterial infections?","volume":"6","author":"Chakraborty","year":"2019","journal-title":"Microb. Cell"},{"key":"10.1016\/j.enzmictec.2025.110760_bib50","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s12010-016-2091-y","article-title":"Refolded recombinant human paraoxonase 1 variant exhibits prophylactic activity against organophosphate poisoning","volume":"180","author":"Bajaj","year":"2016","journal-title":"Appl. Biochem. Biotechnol."},{"key":"10.1016\/j.enzmictec.2025.110760_bib51","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1073\/pnas.2536901100","article-title":"Directed evolution of mammalian paraoxonases PON1 and PON3 for bacterial expression and catalytic specialization","volume":"101","author":"Aharoni","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"1","key":"10.1016\/j.enzmictec.2025.110760_bib52","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.bbrc.2010.10.125","article-title":"Efficient hydrolysis of the chemical warfare nerve agent tabun by recombinant and purified human and rabbit serum paraoxonase 1","volume":"403","author":"Valiyaveettil","year":"2010","journal-title":"Biochem. Biophys. Res. Commun."}],"container-title":["Enzyme and Microbial Technology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141022925001802?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141022925001802?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T12:47:40Z","timestamp":1773146860000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0141022925001802"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":52,"alternative-id":["S0141022925001802"],"URL":"https:\/\/doi.org\/10.1016\/j.enzmictec.2025.110760","relation":{},"ISSN":["0141-0229"],"issn-type":[{"value":"0141-0229","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anti-biofilm efficiency and substrate specificity of recombinantly produced human paraoxonases","name":"articletitle","label":"Article Title"},{"value":"Enzyme and Microbial Technology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.enzmictec.2025.110760","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"110760"}}